Amount Raised
$100 Million
Round Type
Series B
WalthamBiotechnologyDescription
Ventus Therapeutics, Inc., a biotechnology company utilizing rational structure-based drug design to discover small-molecule medicines for high value and elusive targets, today announced a $100 million Series B financing led by RA Capital Management with participation from a select syndicate including BVF Partners L.P., Casdin Capital, Cormorant Asset Management, Fonds de solidarité FTQ, and Alexandria Venture Investments. Founding investor Versant Ventures also participated in the round, as did existing investor GV (formerly Google Ventures).
Quick answer
Ventus Therapeutics raised $100 Million in a Series B round, dated April 8, 2021. Ventus Therapeutics is based in Waltham, Massachusetts, United States.
- How much did Ventus Therapeutics raise?
- Ventus Therapeutics raised $100 Million in a Series B round on April 8, 2021.
- What does Ventus Therapeutics do?
- Ventus Therapeutics is a clinical-stage biopharmaceutical company with two novel small-molecule programs entering Phase 2 development for immunology, inflammation, and neurology disorders.
- Where is Ventus Therapeutics based and how big is it?
- Ventus Therapeutics is based in Waltham, Massachusetts, United States.
- Who are the decision-makers at Ventus Therapeutics?
- Fundz holds 1 contact at Ventus Therapeutics. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Biotechnology around the same time
Companies in the same sectors as Ventus Therapeutics that raised within 45 days of this round, from Fundz verified event records.
- Immunome Inc. raised an undisclosed amount (Grant) on May 20, 2021.
- Numab Therapeutics raised an undisclosed amount (Series C) on May 20, 2021.
- Haya Therapeutics raised an undisclosed amount (Seed) on May 20, 2021.
- Allied BioScience, Inc. raised $250K on May 19, 2021.
- MAIA Biotechnology raised $8M (Funding Round) on May 19, 2021.
- PROXIMITY THERAPEUTICS, INC. raised $2M (Seed) on May 19, 2021.
Who to call at Ventus Therapeutics, and when
A new round usually means Ventus Therapeutics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Ventus Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Ventus Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Ventus Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Ventus Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansVentus Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.